Skip to content

The evaluation of the effect of respiratory rehabilitation training device in early stage of acute exacerbation of chronic obstructive pulmonary disease: a randomized, single center, double blind clinical study

The evaluation of the effect of respiratory rehabilitation training device in early stage of acute exacerbation of chronic obstructive pulmonary disease: a randomized, single center, double blind clinical study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052961
Enrollment
Unknown
Registered
2021-11-06
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation

Interventions

Control group A:Lip contraction breathing training and health education
Control group B:Routine bedside rehabilitation
Intervention group:Routine bedside lung rehabilitation + respiratory rehabilitation trainer

Sponsors

The University of Hong Kong-Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnosis of hospitalized patients with acute exacerbation COPD; 2. Sober consciousness; 3. Able to use the breathing trainer in a sitting position; 4. Subjects agree and sign written informed consent, and they have the ability to comply with the study procedures.

Exclusion criteria

Exclusion criteria: 1. Systolic blood pressure below 90 mmHg; 2. Those with severe infection or high fever; 3. Have a history of malignant tumor; 4. Mental instability, 5. Hemoptysis, pneumothorax 6. Those who need long-term home oxygen therapy, blood oxygen saturation <90%, or supplemented by mechanical ventilation (including non-invasive ventilator-assisted ventilation); 7. There are diseases that interfere with the therapeutic efficacy and safety of the study, such as severe pulmonary hypertension, coronary heart disease with angina pectoris, recent myocardial infarction, etc.

Design outcomes

Primary

MeasureTime frame
6-minute walk test;

Countries

China

Contacts

Public ContactWang Hongxia

The University of Hong Kong-Shenzhen Hospital

wanghx5@hku-szh.org+86 13528460931

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026